Peer Review reports
From: MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by suppressing SDC1 in glioblastoma
| Original Submission | ||
|---|---|---|
| 10 Dec 2023 | Submitted | Original manuscript |
| 7 Jan 2024 | Reviewed | Reviewer Report - Bhrigu Kumar Das |
| 16 Jan 2024 | Reviewed | Reviewer Report |
| 24 Jan 2024 | Author responded | Author comments - Jian Pan |
| Resubmission - Version 2 | ||
| 24 Jan 2024 | Submitted | Manuscript version 2 |
| 1 Feb 2024 | Reviewed | Reviewer Report |
| 3 Feb 2024 | Reviewed | Reviewer Report - Bhrigu Kumar Das |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| Publishing | ||
| 6 Feb 2024 | Editorially accepted | |
| 16 Feb 2024 | Article published | 10.1186/s12885-024-11966-8 |
You can find further information about peer review here.